UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

The American journal of pathology, 2013-05, Vol.182 (5), p.1474-1481

2013

Volltextzugriff (PDF)

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

The New England journal of medicine, 2009-04, Vol.360 (18), p.1851-1861

2009

Volltextzugriff (PDF)

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

The New England journal of medicine, 2008-11, Vol.359 (21), p.2195-2207

2008

Volltextzugriff (PDF)

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

The Lancet (British edition), 2009-04, Vol.373 (9670), p.1175-1182

2009

Volltextzugriff (PDF)

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

The American journal of cardiology, 2012-07, Vol.110 (1), p.3A-14A

2012

Volltextzugriff (PDF)

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

The New England journal of medicine, 2001-06, Vol.344 (26), p.1959-1965

2001

Volltextzugriff (PDF)

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

JAMA : the journal of the American Medical Association, 2012-03, Vol.307 (12), p.1302

2012

Volltextzugriff (PDF)

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

The American journal of cardiology, 2014, Vol.113 (1), p.76-83

2014

Volltextzugriff (PDF)

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

The American journal of pathology, 2019-03, Vol.189 (3), p.492-501

2019

Volltextzugriff (PDF)

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

The Lancet (British edition), 2010-07, Vol.376 (9738), p.333-339

2010

Volltextzugriff (PDF)

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

The American journal of cardiology, 2012-07, Vol.110 (1), p.15A-26A

2012

Volltextzugriff (PDF)

Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester

The Journal of biological chemistry, 2017-05, Vol.292 (21), p.8864-8873

2017

Volltextzugriff (PDF)

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

The American journal of cardiology, 2004-01, Vol.93 (2), p.136-141

2004

Volltextzugriff (PDF)

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

The American journal of cardiology, 2010-05, Vol.105 (9), p.1289-1296

2010

Volltextzugriff (PDF)

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

The American journal of cardiology, 2007-03, Vol.99 (5), p.718-725

Gotto, Antonio M., MD, DPhil

2007

Volltextzugriff (PDF)

Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study)

The American journal of cardiology, 2009-09, Vol.104 (6), p.829-834

2009

Volltextzugriff (PDF)

Update on the evaluation and management of cardiovascular risk. Introduction

The American journal of cardiology, 2012-07, Vol.110 (1 Suppl), p.1A-2A

Gotto, Jr, Antonio M

2012

Volltextzugriff (PDF)

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

The American journal of cardiology, 2007-12, Vol.100 (11), p.1659-1664

2007

Volltextzugriff (PDF)

Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations

The American journal of cardiology, 2014-01, Vol.113 (2), p.302-308

2014

Volltextzugriff (PDF)

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

Annals of internal medicine, 2005-01, Vol.142 (2), p.95

2005

Volltextzugriff (PDF)

Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression: A NEW SREBP1-DEPENDENT MECHANISM

The Journal of biological chemistry, 2008-01, Vol.283 (4), p.2129-2138

2008

Volltextzugriff (PDF)

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

The New England journal of medicine, 2010-12, Vol.363 (25), p.2406-2415

2010

Volltextzugriff (PDF)

Statins, Cardiovascular Disease, and Drug Safety

The American journal of cardiology, 2006-04, Vol.97 (8), p.S3-S5

Gotto, Antonio M.

2006

Volltextzugriff (PDF)

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

The American journal of cardiology, 2002-02, Vol.89 (3), p.268-275

2002

Volltextzugriff (PDF)

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

The New England journal of medicine, 2007-09, Vol.357 (13), p.1301-1310

2007

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Englisch
(240)

Erscheinungsjahr

n.n

Thema

Humans
(153)
Science & Technology
(150)
Life Sciences & Biomedicine
(139)
Biological And Medical Sciences
(76)
Medical Sciences
(69)
Male
(62)
Cardiac & Cardiovascular Systems
(53)
Cardiovascular System & Cardiology
(53)
Female
(53)
Cardiovascular Disease
(49)
Middle Aged
(48)
Cholesterol
(46)
General & Internal Medicine
(44)
Medicine, General & Internal
(44)
Risk Factors
(41)
Adult
(37)
Cholesterol, Ldl - Blood
(35)
Lipids
(30)
Aged
(29)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biological Relevance of Inflammation and Oxidative Stress in the Pathogenesis of Arterial Diseases

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Recent Clinical Studies of the Effects of Lipid-Modifying Therapies

Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study)

Update on the evaluation and management of cardiovascular risk. Introduction

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression: A NEW SREBP1-DEPENDENT MECHANISM

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Statins, Cardiovascular Disease, and Drug Safety

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

Aktive Filter

Suchergebnisse filtern